Shipping calculated by weight — US, Canada, Mexico & Europe
Ponyon
SLU-PP-332 5mg

SLU-PP-332 5mg

品牌: Ponyon

SLU-PP-332 is an experimental small-molecule estrogen-related receptor (ERR) agonist studied for mitochondrial function, oxidative metabolism, energy expenditure, fatty acid oxidation, and metabolic adaptation in skeletal muscle.

US$143.00
有货

SKU SLU-PP-322 · 30 天内可退货

SLU-PP-332 is an experimental small-molecule compound investigated in metabolic, mitochondrial, and exercise-physiology research, primarily through its activity involving Estrogen-Related Receptors (ERRs).

ERRs are members of the nuclear receptor family. ERRα (ESRRA), ERRβ (ESRRB), and ERRγ (ESRRG) participate in the regulation of cellular energy metabolism, mitochondrial function, and oxidative metabolic gene programs. SLU-PP-332 is studied as an ERR agonist and experimental tool for investigating these pathways.

In cellular and metabolic research, SLU-PP-332 has been investigated in connection with mitochondrial respiration, oxidative phosphorylation, fatty acid oxidation, glucose and lipid metabolism, and cellular energy homeostasis.

SLU-PP-332 has also attracted interest in exercise-metabolism research, particularly for studying relationships between ERR signaling and skeletal-muscle oxidative capacity, mitochondrial adaptation, energy expenditure, and exercise-associated metabolic programs.

It is sometimes described as an “exercise mimetic” in research and media contexts. This terminology refers to experimental metabolic effects and does not establish that SLU-PP-332 can safely replace physical exercise or reproduce all of its effects in humans.

SLU-PP-332 remains an experimental research compound, with evidence largely derived from preclinical models. Current findings do not establish proven human benefits for endurance enhancement, fat loss, athletic performance, obesity treatment, or other metabolic conditions.

用户评价

暂无评价

来写下第一条评价吧。

完善你的方案

* 以上声明未经美国食品药品监督管理局(FDA)评估。本产品不用于诊断、治疗、治愈或预防任何疾病。孕期、哺乳期、服药或患有疾病者请先咨询医生。